Literature DB >> 17065789

Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.

C Jin1, Y Jin, D Gisselsson, J Wennerberg, T S Wah, B Strömbäck, Y-L Kwong, F Mertens.   

Abstract

Amplification of 11q13 DNA sequences and overexpression of CCND1 are common findings in head and neck squamous cell carcinoma (HNSCC), identified in about 30% of the cases. However, little is known about initiation of the amplification and the organization of the amplicon. In order to study the structure of the amplicon in more detail and to learn more about the mechanisms involved in its initiation, prometaphase, metaphase, and anaphase fluorescence in situ hybridization (FISH) with 40 BAC clones spanning a 16-Mb region in chromosome bands 11q12.2 to 11q13.5 was performed in nine HNSCC cell lines with homogeneously staining regions. FISH analysis showed that the size of the amplicon varied among the nine cell lines, the smallest being 2.12 Mb and the largest 8.97 Mb. The smallest overlapping region of amplification was approximately 1.61 Mb, covering the region from BAC 729E14 to BAC 102B19. This region contained several genes previously shown to be amplified and overexpressed in HNSCC, including CCDN1, CTTN, SHANK2, and ORAOV1. The cell lines were also used to study the internal structure of the amplicon. Various patterns of amplified DNA sequences within the amplicon were found among the nine cell lines. Even within the same cell line, different amplicon structures could be found in different cell populations, indicating that the mechanisms involved in the development of the amplicons in HNSCC were more complex than previously assumed. The frequent finding of inverted repeats within the amplicons, however, suggests that breakage-fusion-bridge cycles are important in the initiation, but the fact that such repeats constituted only small parts of the amplicons indicate that they are further rearranged during tumor progression. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065789     DOI: 10.1159/000095228

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  14 in total

1.  Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization.

Authors:  Małgorzata Jarmuz-Szymczak; Kinga Pelinska; Magdalena Kostrzewska-Poczekaj; Ewa Bembnista; Maciej Giefing; Damian Brauze; Marcin Szaumkessel; Andrzej Marszalek; Joanna Janiszewska; Katarzyna Kiwerska; Anna Bartochowska; Reidar Grenman; Witold Szyfter; Krzysztof Szyfter
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

2.  Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.

Authors:  Adrian Britschgi; Anke Bill; Heike Brinkhaus; Christopher Rothwell; Ieuan Clay; Stephan Duss; Michael Rebhan; Pichai Raman; Chantale T Guy; Kristie Wetzel; Elizabeth George; M Oana Popa; Sarah Lilley; Hedaythul Choudhury; Martin Gosling; Louis Wang; Stephanie Fitzgerald; Jason Borawski; Jonathan Baffoe; Mark Labow; L Alex Gaither; Mohamed Bentires-Alj
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.

Authors:  Ilda Patrícia Ribeiro; Francisco Marques; Francisco Caramelo; João Pereira; Miguel Patrício; Hugo Prazeres; José Ferrão; Maria José Julião; Miguel Castelo-Branco; Joana Barbosa de Melo; Isabel Poiares Baptista; Isabel Marques Carreira
Journal:  Cell Oncol (Dordr)       Date:  2013-12-19       Impact factor: 6.730

4.  (Cyto)genomic and epigenetic characterization of BICR 10 cell line and three new established primary human head and neck squamous cell carcinoma cultures.

Authors:  Ilda P Ribeiro; Joana M Rodrigues; Alexandra Mascarenhas; Vanessa Marques; Francisco Caramelo; Maria J Julião; Thomas Liehr; Joana B Melo; Isabel M Carreira
Journal:  Genes Genomics       Date:  2019-07-18       Impact factor: 1.839

Review 5.  Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma.

Authors:  Pooja Karukonda; Diana Odhiambo; Yvonne M Mowery
Journal:  Mol Carcinog       Date:  2021-12-29       Impact factor: 4.784

6.  Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Authors:  Madhav Sankunny; Rahul A Parikh; Dale W Lewis; William E Gooding; William S Saunders; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-25       Impact factor: 5.006

Review 7.  Classification of chromosome segregation errors in cancer.

Authors:  David Gisselsson
Journal:  Chromosoma       Date:  2008-06-06       Impact factor: 4.316

Review 8.  Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.

Authors:  Christa Lese Martin; Shalini C Reshmi; Thomas Ried; William Gottberg; John W Wilson; Jaya K Reddy; Poornima Khanna; Jonas T Johnson; Eugene N Myers; Susanne M Gollin
Journal:  Oral Oncol       Date:  2007-08-02       Impact factor: 5.337

9.  Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors.

Authors:  Javier Del Rey; Esther Prat; Immaculada Ponsa; Josep Lloreta; Antoni Gelabert; Ferran Algaba; Jordi Camps; Rosa Miró
Journal:  BMC Cancer       Date:  2010-06-11       Impact factor: 4.430

10.  Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors.

Authors:  Jia-Jie Hao; Zhi-Zhou Shi; Zhi-Xin Zhao; Yu Zhang; Ting Gong; Chun-Xiang Li; Ting Zhan; Yan Cai; Jin-Tang Dong; Song-Bin Fu; Qi-Min Zhan; Ming-Rong Wang
Journal:  BMC Cancer       Date:  2012-08-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.